Addiction one of the Largest growing Problem’s in the world today. This Press Release Service will bring you the newest services and research available.
“The demand for a fresh definition of what providers expect of their EHRs is sweeping our industry. With Geisler IT Services, we can accelerate our plans to provide our customers with a complete platform,” said Alan Tillinghast,” CEO of Cantata Health Solutions. “The GOSH System enables us to optimize the workflows shared by MCOs and service providers. With better integration between providers and payers, the administrative burden placed on providers is reduced, allowing them to focus more efforts on person centered care.”
The entire Geisler IT Services team will join Cantata Health Solutions, bringing their deep industry knowledge and experience to the Cantata team. Their ongoing involvement will ensure a seamless transition and continued innovation of the GOSH System and beyond.
“We are excited to join forces with Cantata Health Solutions,” said Mike Geisler, founder of Geisler IT Services. “Over the past decade, we’ve offered a unique technology solution that has significantly improved processes for our customers. We’re excited to enter this next chapter, where we can further enhance support for the ADAMH Boards in Ohio while leveraging Cantata’s sales and marketing resources to expand our reach nationwide.”
The acquisition of Geisler IT Services underscores Cantata Health Solutions’ dedication to delivering solutions designed to address the challenges today’s behavioral health and human services providers have with their legacy EHR systems by replacing them with modern technology that gives clinicians, staff, and clients a whole new way to work and collaborate. For more information about Cantata’s Arize EHR platform, visit: https://cantatahealth.com/arize-ehr/.
About Cantata Health Solutions Built by behavioral health industry veterans, Cantata Health Solution’s Arize care management platform provides a modern EHR, a complete billing and revenue cycle management solution, and an extensive array of client engagement tools. Arize offers clinicians, executives, back-office staff, and clients a collaborative view of the health record. In an industry dedicated to serving the most vulnerable population, its mission is to provide technology that empowers so providers don’t have to rely on legacy systems that only hinder their progress. For more information, visit CantataHealth.com.
Twenty Master of Science in Nursing–Entry (MSN-E) students will receive scholarships from the Strategically Transforming and Advancing Nursing Diversity (STAND) grant. CGN received a $1.64 million Strategically Transforming and Advancing Nursing Diversity (STAND) grant from HRSA to provide scholarships to underrepresented minority nursing students and supportive services to help them succeed. The funding supports 20 MSN-E students per year for three years. The MSN-E students starting today represents the third cohort of STAND scholarship recipients. Read more about the first STAND Scholars.
More than 140 Psychiatric Mental Health Nurse Practitioner (PMHNP) students are receiving support from the California Department of Health Care Access and Information (HCAI) Psychiatric Education Capacity Expansion (PECE) Psychiatric Mental Health Nurse Practitioners Grant Program. CGN received a $7,912,000 grant from the HCAI in 2022. HRSA awarded CGN $1.875 million to create a Behavioral Workforce Education Training (BWET) program to enhance mental health services in the region. The BWET program also created the region’s first Behavioral Health Training Center. The first cohort of WesternU PMHNP students started in August 2021.
“CGN is proud to help support the mental health needs of California,” said CGN Associate Dean for Administration and Research Rodney W. Hicks, PhD, RN, FNP-BC, FAANP, FNAP, FAAN. “California currently is experiencing an increased demand for mental health services for clients of all ages at the time that the number of practicing psychiatrists is dwindling. Psychiatric Mental Health Nurse Practitioners are assessing, diagnosing, and treating the mental health needs of clients and families. Our grants are increasing the number of PMHNPs to fill the need.”
“Our Inland Empire region lags behind other California regions in meeting mental health needs,” said CGN PMHNP Program Director Christy Cotner, DNP, PMHNP-BC, FNP-BC. “I am overjoyed at WesternU’s head-on approach to meeting our region’s needs. Having financial support for our students will truly make a difference in our region.”
“California is facing a nursing shortage. Part of the causes of the nursing shortage is the lack of qualified nursing faculty,” Lopez said. “Our college participates with HRSA on the National Faculty Loan Program to educate the next generation of nursing faculty. So far, we have educated more than 440 faculty members. This year, we expect to educate another 25. Moreover, half the participants represent populations not typically seen in nursing faculty. We are making a difference.”
The Inc. 5000 provides a data-driven look at the most successful independent, entrepreneurial businesses according to the percentage revenue growth of a company from 2020 to 2023. To qualify, companies must be U.S.-based, privately held, for-profit, and independent—not subsidiaries or divisions of other companies. Of the companies on the 2024 list, AvevoRx ranked 581 out of 5,000.
“We are thankful to have an amazing team constantly delivering phenomenal patient care. That is the core of our sustained growth,” said Eric Hill, Co-Founder of AvevoRx. “The trust that we have attained from our patients and physician partners is something we hope to continue to earn every single day, well into the future.”
As it grows, AvevoRx remains focused on providing the same speed, service, and simplicity that have enabled the company to gain prominence in the industry.
“Achieving this level of growth has been a direct result of our dedication and teamwork,” said Lauren Pumphrey, Co-Founder and Executive Vice President. “This ranking highlights our success and reflects the strong partnerships and trust we’ve built with patients and physicians.”
Inc. 5000 Methodology
The 2024 Inc. 5000 companies are ranked according to percentage revenue growth from 2020 to 2023. To qualify, companies must have been founded and have generated revenue by March 31, 2020. They must also be U.S.-based, privately held, for-profit, and independent by December 31, 2023. The minimum revenue required for 2020 is $100,000; the minimum for 2023 is $2 million. Growth rates used to determine company rankings were calculated to four decimal places. For more information, visit www.inc.com/inc5000.
AvevoRx is a national, independent provider of specialty infusion pharmacy services. The company focuses on the highest-quality, personalized care customized to patients with complex, chronic disorders. Treatments are made available via specialized pharmacy locations, field nurses, and additional support staff throughout the United States. AvevoRx also provides acute infusion therapies on a regional basis for patients with short-term therapeutic needs. Privately held, the company was founded in 2021 by a small group of industry veterans with a combined experience of more than 130 years. AvevoRx is headquartered in North Carolina. To learn more, visit www.AvevoRx.com or follow us on Instagram or LinkedIn.
About Inc.
Inc. Business Media is the leading multimedia brand for entrepreneurs. Through its journalism, Inc. aims to inform, educate, and elevate the profile of our community: the risk-takers, the innovators, and the ultra-driven go-getters who are creating our future. Inc.’s award-winning work achieves a monthly brand footprint of more than 40 million across a variety of channels, including events, print, digital, video, podcasts, newsletters, and social media. Its proprietary Inc. 5000 list, produced every year since its launch as the Inc. 100 in 1982, analyzes company data to rank the fastest-growing privately held businesses in the United States. The recognition that comes with inclusion on this and other prestigious Inc. lists, such as Female Founders and Power Partners, gives the founders of top businesses the opportunity to engage with an exclusive community of their peers, and credibility that helps them drive sales and recruit talent. For more information, visit www.inc.com.
Register for this webinar to learn more about how organizations can apply AI for the clinical protocol development process, critically evaluate AI-based solutions to ensure they are fit for purpose and how organizations can be set up for success by adopting tools to accelerate clinical development.
Join Patrick Leung, CTO, Faro Health Inc., for the live webinar on Thursday, September 12, 2024, at 3pm EDT (12pm PDT).
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
How does AltaPointe’s First Episode Psychosis program help those who are experiencing these symptoms?
AltaPointe Health’s FEP program is designed to provide comprehensive support to individuals experiencing their first episode of psychosis. It offers a combination of therapeutic services, medication management, and educational support. The goal is to treat the symptoms and help individuals and their families understand what they’re experiencing and how to move forward. The program is holistic, addressing both the clinical and personal aspects of recovery.
What are some of the early signs that someone might be experiencing psychosis?
Some of the early signs can be subtle but are important to recognize. They might include a sudden drop in performance at school or work, withdrawal from friends and family, difficulty concentrating, or unusual thoughts or behaviors. If these symptoms persist or worsen, it’s essential to seek professional help as soon as possible.
How can someone access the FEP program at AltaPointe if they think they or a loved one might be experiencing these early signs?
Getting connected with the FEP program at AltaPointe is straightforward. If you or someone you know is showing signs of psychosis, you can reach out directly. “We offer initial assessments to determine if our program is the right fit, and from there, we work closely with individuals and their families to develop a personalized treatment plan,” said Currie.
AltaPointe’s First Episode Psychosis program received program certification in February 2020. Staff members work with young people between the ages of 15 and 25 who are experiencing their first psychotic episodes.
To learn more about the FEP program and other AltaPointe programs and services, call the access to care line at (251) 450-2211.
AltaPointe Health is an extensive healthcare system providing primary and behavioral healthcare. Each year, it provides more than 1 million services to 45,000 patients across Alabama. A national leader in behavioral health for more than 60 years, AltaPointe expanded its service array in 2018 to include primary care.
Media Contact
April Douglas, AltaPointe Health, 251-544-4639, [email protected], altapointe.org
The 2024 fellowships are financially supported through the Forward Fund, which was established by SITC to stimulate the future of science, development, and application of cancer immunology and immunotherapy by financially supporting its education and research. Since 2014, SITC has awarded more than $6 million in funding to deserving early career scientists in the field of cancer immunotherapy. SITC will recognize the recipients during its 39th Annual Meeting, occurring in November at the George R. Brown Convention Center, Houston, TX.
The 2024 SITC Forward Fund fellowship recipients are:
SITC-Bristol Myers Squibb Postdoctoral Cancer Immunotherapy Translational Fellowship Award Amount: $200,000 (two year) Awardee: Elisa Bergaggio, PhD Institution: Boston Children’s Hospital Project Title: “Enhancing ALK.CAR-T efficacy in solid tumors”
SITC-MRA Women in Melanoma Fellowship Award Amount: $200,000 (two year) Awardee: Arielle Elkrief, MD Institution: University of Montreal Project Title: “Identification of the next generation of microbiome therapeutics in combination with immune checkpoint blockade to improve outcomes for patients with melanoma”
SITC-Merck Cancer Immunotherapy Clinical Fellowship Award Amount: $100,000 (one year) Awardee: Benjamin R. Schrank, MD, PhD Institution: The University of Texas MD Anderson Cancer Center Project Title: “Enhancing Tumor-Immune Interactions in Breast Cancer via an Immunostimulatory Antibody-Drug Conjugate”
SITC Diversity, Equity and Inclusion Fellowship Award Amount: $100,000 (one year) Awardee: Victor Arrieta, MD, PhD Institution: Northwestern University Project Title: “Leveraging DNA Methylation Signatures to Decode Clinical Responses to Immune Checkpoint Blockade in Glioblastoma”
SITC-Mallinckrodt Pharmaceuticals Adverse Events in Cancer Immunotherapy Clinical Fellowship Award Amount: $40,000 (one-year) Awardee: Gabriele Casirati, MD, PhD Institution: Dana-Farber Cancer Institute Project Title: “Epitope edited Hematopoietic Stem Cells to Eliminate On-target/Off-tumor Toxicity”
The 2024 SITC Forward Fund fellowships were made possible through the generosity of Bristol Myers Squibb, Mallinckrodt Pharmaceuticals, Melanoma Research Alliance and Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc.
To learn more about current and past SITC fellowship recipients, visit the SITC website.
About SITC Established in 1984, the Society for Immunotherapy of Cancer (SITC) is a nonprofit organization of medical professionals dedicated to improving cancer patient outcomes by advancing the development, science and application of cancer immunotherapy and tumor immunology. SITC is comprised of influential basic and translational scientists, practitioners, health care professionals, government leaders and industry professionals around the globe. Through educational initiatives that foster scientific exchange and collaboration among leaders in the field, SITC aims to one day make the word “cure” a reality for cancer patients everywhere. Learn more about SITC, our educational offerings and other resources at sitcancer.org and follow us on X, LinkedIn, Facebook, Instagram and YouTube.
Media Contact
Thomas Martin, Society for Immunotherapy of Cancer (SITC), 414-271-2456, [email protected], sitcancer.org
Government-supported at the national, state and local levels, the RFW-FL Coalition is a groundbreaking initiative tasked with solving the complex challenges of addiction and recovery in the workplace. In addition to government backing, Florida’s RFW Coalition includes the support of local and state businesses, training and educational institutions, the state’s extensive treatment community as well as individuals in recovery.
NET to Drive RFW-FL Efforts
The NET Training Institute (NTI), a leading nonprofit organization dedicated to advancing workplace wellness, has been appointed to spearhead Florida’s RFW initiatives. As the official Administrative Agency, this designation highlights NTI’s commitment to creating supportive and recovery-focused work environments. In this capacity NTI will produce a Center of Excellence for Florida’s participation in this critical nationwide effort.
The RFW-FL Coalition’s leadership team includes Co-chairs Merriwether and Richard Riccardi, founder and CEO of Fellowship Recovery Community Organization. Ashley Grimes has been named Executive Director.
Cheryl Brown Merriwether brings over two decades of experience in corporate HR management and addiction recovery awareness to her role at NTI, where she oversees operations and student support services. Merriwether is the Immediate Past President of the Greater Orlando Society for Human Resources (GOSHRM) and an active Board Member of Project Opioid.
Richard (Rick) Riccardi founded the Fellowship Recovery Community Organization, a nonprofit providing recovery support services across Broward County. With 30 years in long-term recovery, Riccardi advocates for those with substance use disorders and holds several leadership roles in local community organizations. Connect on LinkedIn.
Ashley Grimes brings her expertise in the addiction community to the RFW-FL Coalition. Past President of the Florida National Alliance on Mental Illness (NAMI) Board and Executive Director of NAMI FL, Grimes is an iconic figure in the mental health/recovery community. She was named to the Florida Health Care Power 100 recognizing key influencers. Connect on LinkedIn.
National Roots Take Hold
The RFW concept began in New Hampshire in 2018 under Governor Sununu and has gained national traction. In November 2023, the Biden-Harris administration released the Recovery-Ready Workplace Toolkit for organizations seeking to create a recovery supportive culture. The Global Recovery Initiatives Foundation (GRI) established the National RFW Institute in January 2024. The nationwide effort aims to create healthy and safe workplaces, support workers who are struggling with substance use disorder, and facilitate opportunities for individuals in recovery to enter or reenter the workforce.
The RFW-FL initiative signals a collaborative effort between federal and state governments to address substance use disorder as a medical condition. This partnership underscores the importance of implementing solutions at both the state and national levels to support individuals in recovery.
Merriwether’s appointment to the National Recovery Friendly Workplace Institute’s Steering Committee earlier this year is a notable achievement. These national standards for RFW certification for large-scale employers across multiple states were established in May 2024. The Florida RFW Coalition is tasked with creating its own state-level standards and certification processes that can mirror or deviate from national standards based on Florida’s unique addiction challenges.
About NET Training Institute (NTI)
NET Training Institute (NTI) is dedicated to nurturing, equipping, and training front-line workers and professionals seeking practical skills in addiction recovery. Since its inception in 1996, NTI has focused on providing hands-on training for counselors, therapists, and other practitioners.
Incorporated as a 501(c)(3) nonprofit in 1998, NTI has trained 40,000 students worldwide, including those from India, Egypt, Russia, Finland, Ghana, Ireland, Central and South America, Pakistan, South Africa, the Philippines, Singapore, Iran, Sri Lanka, the UK, Canada, and Bermuda.
NTI’s curriculum adheres to international standards set by various professional addiction certification boards, offering a unique and comprehensive training experience. The NET Training Institute remains committed to advancing addiction recovery education with a focus on practical, applicable skills for professionals across the globe. Visit NTI’s website for additional information.
Media Contact
Elizabeth Fairleigh, thE Connection, 1 404 6954562, [email protected] , thE Connection
“While GLP-1 treatments are currently expensive, there is an argument that they could be cost-effective over time due to their potential to reduce complications related to diabetes and cardiovascular events,” says Josh Schreiner, Chief Product Officer at HealthEZ. “Investing in obesity treatment may result in long-term savings by preventing the onset or progression of obesity-related issues like type 2 diabetes, and result in improved employee health.”
Given these factors, employers must consider both immediate financial implications and future health outcomes when deciding on health plan coverage.
In the meantime, HealthEZ says a comprehensive approach to obesity management should be anchored in a smart wellness and weight loss program. HealthEZ has developed an effective program that has demonstrated strong employee engagement which is based on coaching and having registered nurses on staff, and uses educational lunch-and-learns and webinars to enhance the approach.
“Wellness programs that provide nutritional guidance, physical activity support and behavioral counseling remain a key in addressing this issue to help employees,” says Schreiner. “By providing access to a multidisciplinary approach, employers can enhance the efficacy of GLP-1 treatments and support sustainable lifestyle changes.”
Based in Bloomington, Minnesota, HealthEZ is a national independent third-party administrator of employer-sponsored, self-funded medical plans and America’s PPO, the nation’s first preferred provider organization. On a mission to make health insurance easy to understand and more efficient from provider to patient and the employers who fund their plans, HealthEZ launched EZ Pay, the nation’s first consumer medical “tap & pay” app making bills easier to understand and simpler to pay. The company partners with employers throughout the United States to deliver better access to healthcare for their employees while ensuring value and improving outcomes. More information about HealthEZ can be found at www.healthez.com.
Enhanced Patient Comfort: Traditional dental impressions can be messy and uncomfortable. The Itero Scanner eliminates the need for these molds, providing a much more comfortable experience for patients.
Exceptional Accuracy: The high-resolution 3D images produced by the Itero Scanner offer unparalleled precision. This results in better-fitting restorations, crowns, bridges, and orthodontic appliances, ensuring optimal patient outcomes.
Faster Turnaround Times: Digital impressions can be transmitted instantly to dental labs, significantly reducing the time required to fabricate dental appliances. This means patients can enjoy quicker turnaround times and fewer visits to the dentist.
Improved Monitoring and Preventive Care: The Itero Scanner allows for detailed tracking of changes in dental health over time. This capability is invaluable for preventive care, enabling Dr. Gutierrez and her team to detect and address potential issues before they become more serious.
Dr. Maria Gutierrez’s Commitment to Excellence Dr. Maria Gutierrez is widely recognized for her dedication to incorporating the latest advancements in dental technology into her practice. Her commitment to excellence is reflected in every aspect of patient care at Majestic Smile Studio.
“We are thrilled to integrate the Itero Scanner into our practice,” said Dr. Gutierrez. “This technology not only enhances the precision and quality of our treatments but also significantly improves the overall patient experience. We are committed to providing our patients with the best possible care, and the Itero Scanner is a testament to that commitment.”
About Majestic Smile Studio Majestic Smile Studio, conveniently located in the heart of Yorba Linda, CA, is a premier dental practice renowned for its exceptional patient care and comprehensive range of dental services. Under the leadership of Dr. Maria Gutierrez, the practice offers a wide array of treatments, including preventive care, cosmetic dentistry, restorative dentistry, and orthodontics. The dedicated team at Majestic Smile Studio is passionate about creating healthy, beautiful smiles for patients of all ages and backgrounds.
Patient-Centric Approach At Majestic Smile Studio, patient satisfaction and comfort are paramount. The addition of the Itero Scanner reflects the practice’s patient-centric approach, which aims to make dental visits as pleasant and efficient as possible. The practice’s welcoming atmosphere, combined with the expertise of Dr. Gutierrez and her team, ensures that every patient receives personalized care tailored to their unique needs.
For more information about the Itero Scanner and the comprehensive range of dental services offered at Majestic Smile Studio, please visit our website or contact our office directly. We look forward to welcoming you to our practice and providing you with the exceptional dental care you deserve.
Assessing the quality and specifications is often a challenge in this regulatory grey area because the International Council for Harmonisation (ICH) guidelines consider this modality as a chemical entity while sharing properties with biologics.
Therefore, a thorough understanding of oligonucleotide’s mechanism of action, safety aspects and the production process helps with informed decision-making for the chemistry, manufacturing and controls’ (CMC) critical quality attributes (CQAs).
In this webinar, the expert speakers will share insights on oligonucleotide therapeutics as an emerging therapeutic modality and focus on their production processes, drug substance specifications, material properties and potential impurities. They will also explore CMC Investigational Medicinal Product (IMP) considerations specific to oligonucleotides, including the identification of CQAs and critical process parameters (CPPs) essential for drug development.
They will also discuss key manufacturing aspects, as well as stability and scalability concerns for oligonucleotide therapeutics, to ensure a thorough understanding of the production lifecycle. Moreover, this webinar will provide guidance on progressing into early-phase clinical studies and emphasize on how to set and meet specifications to maintain quality and comply with regulatory standards, thus ensuring a smooth transition from development to clinical evaluation.
Register for this webinar today to gain expert insights into the complex regulatory landscape of oligonucleotide therapeutics.
Join ICON, André Boltjes, PhD, Project Director CMC; Pascal van Tilburg, BSc, Senior Project Manager and SME in CMC; and Jasper Boonstra, PharmD, PhD, Qualified Person, for the live webinar on Wednesday, September 4, 2024, at 10am EDT (4pm CEST/EU-Central).
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
